Our portfolio of innovative therapies is designed to meet the unique needs of several underserved patient populations.

Products

Carbaglu® (carglumic acid dispersible tablets)

Cosmegen® (dactinomycin for injection)

Cystadane® (betaine anhydrous powder for oral solution)

Panhematin® (hemin for injection)

For Medical Information Requests:

medinfocanada@recordatirarediseases.com

Adverse Event Reporting:

1-905-827-1300 (M-F 8:30 AM-5 PM ET)
1-877-827-1306 (M-F 8:30 AM-5 PM ET) Toll-Free
drugsafety@mckesson.ca

Adverse events can be reported directly to Health Canada. For information on how to report to Health Canada, please visit the Adverse Reaction and Medical Device Problem Reporting page on Health Canada’s website.

Related Websites:

Support & Resources

Our top priority is meeting the needs of the rare disease community.

LEARN MORE

Contact Us

Contact Recordati Rare Diseases Canada.

LEARN MORE